Form 8-K - Current report:
SEC Accession No. 0001641172-25-005788
Filing Date
2025-04-23
Accepted
2025-04-23 09:15:09
Documents
14
Period of Report
2025-04-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39417
2 ex99-1.htm EX-99.1 19349
  Complete submission text file 0001641172-25-005788.txt   234403

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocea-20250422.xsd EX-101.SCH 3036
4 XBRL LABEL FILE ocea-20250422_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ocea-20250422_pre.xml EX-101.PRE 22373
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3463
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 25859409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)